Gene Query: TUBB4A

Dataset Description Geneva Score
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 107.41
HEXIM1 is induced by DHODH inhibition to suppress melanoma 84.26
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 84.26
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 68.26
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 67.32
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 66.22
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 63.89
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 60.9
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 56.0
RNA-sequencing of formalin fixed human primary melanoma tissue 55.65
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 55.62
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 54.91
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 47.91
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 45.76
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 44.12
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 44.0
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 43.31
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 37.18
AMPK signaling for naïve pluripotency [Hs] 33.65
AMPK signaling for naïve pluripotency 33.65
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 32.11
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 31.36
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 30.95
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 30.79
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 30.48
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 30.13
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 28.7
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 28.7
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 27.17
circRNA-sequencing 27.1
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 26.84
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 25.64
MYCi361 regulates MYC target genes 25.37
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 25.12
Examining serotonergic neuron differentiation from human iPSCs 24.86
Epigenomic landscape during organ formation in human early embryos 24.84
Cell responses to dysregulated VZV-induced cell-cell fusion 24.66
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 24.43
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 22.85
Human HAP1 cells before and after nutrient deprivation 22.85
CDK4/6 inhibitor resistance in prostate cancer 22.41
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 21.95
Control of prostate tumour growth by the long non-coding RNA GHSROS 21.78
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 21.75
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 21.67
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 21.32
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 21.32
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 20.94
Transcriptome analysis of BAP1 knockout and restoration 20.94
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 20.79
ARID1A and ARID1B loss in HCT116 cells 20.61
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 20.01
RNA-seq of naive and primed ES cells 19.96
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 19.81
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 19.42
Global gene expression profile of dasatinib-resistant RCH-ACV cells 19.4
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 19.12
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 18.99
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 18.93
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 17.93
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 17.77
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 17.66
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 17.59
HNRNPL and its RNA Targets in Prostate Cancer 17.45
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 17.45
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 17.3
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 17.03
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 17.03
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 16.49
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 16.47
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 16.36
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 16.36
Universal alternative splicing of noncoding exons 16.12
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 16.1
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 16.06
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 16.04
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 16.04
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 15.86
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 15.81
Transcriptional landscape changes during human embryonic stem cell derivation 15.23
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 15.16
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 14.93
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 14.93
nELAVL HITS-CLIP in Alzheimer's Disease patients 14.93
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 14.84
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 14.84
Subtle asymmetry of gene expression in embryonic and foetal human brains 14.55
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 14.53
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 14.12
Genome-wide chromatin analysis of Ewing sarcoma 14.12
Total RNA sequencing of APC mutant and wt colonic organoids 13.97
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 13.97
Differentiation enhances Zika virus infection in neuronal brain cells 13.96
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 13.96
Human ovarian granulosa cell transcriptome 13.6
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 13.59
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 13.53
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 13.24
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 13.24
Repurposing of promoters and enhancers during mammalian evolution 13.15
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 13.14
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 13.04
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 13.04
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 12.95
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 12.91
Molecular Criteria for Defining the Naive Human Pluripotent State 12.9
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 12.9
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 12.89
Gene expression changes in human melanoma cell lines compared to primary melanocytes 12.73
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 12.63
Next Generation Sequencing of human SMA and healthy control Motor Neurons 12.59
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 12.55
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 12.42
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 12.42
RNA-seq of human aneuploid cell lines with Trisomy 21 12.17
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 11.95
Depicting early human development and germ cell origin with porcine embryos 11.64
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 11.57
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 11.57
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 11.51
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 11.41
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 11.2
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 11.09
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 11.03
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 10.89
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 10.88
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 10.88
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 10.75
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 10.71
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 10.65
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 10.65
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 10.54
Rorc disruption in human FG pancreatic cancer cells 10.42
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 10.4
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 10.39
Total RNA sequencing of WT intestinal orgaonids. 10.29
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 10.29
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 10.2
Transcriptome-wide identification of CELF2 functional targets in T cells 10.2
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 10.14
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 10.1
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 10.01
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 9.95
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 9.94
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 9.93
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 9.93
Disruption of GRIN2B impairs differentiation in human neurons 9.86
AR-independent prostate cancer is sustained through FGF signaling 9.81
The role of FAM46C in myeloma cells [sequencing] 9.75
The role of FAM46C in myeloma cells 9.75
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 9.63
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 9.59
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 9.59
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 9.48
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 9.48
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 9.47
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 9.45
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 9.42
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 9.39
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 9.19
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 9.14
Alteration of the microRNA network during the progression of Alzheimer’s disease 8.96
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 8.85
Gene expression patterns define the hepatocyte-like cells derived by different strategies 8.85
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 8.81
Gene expression changes upon drug withdrawal (Mel888 cell line) 8.8
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 8.66
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 8.66
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 8.66
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 8.62
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 8.56
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 8.55
Impact of dieldrin on transcription in Jurkat T cells 8.46
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 8.44
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 8.27
Dissecting neural differentiation regulatory networks through epigenetic footprinting 8.24
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 8.22
TGF-β promotes genomic instability after loss of RUNX3 8.05
Genome-wide functional assessment of enhancer activities in the human genome 8.04
An integrative analysis of non-coding regulatory DNA variations associated with autism 7.94
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 7.92
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 7.84
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 7.84
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 7.78
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 7.68
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 7.68
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 7.64
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 7.64
Transposon-based construction of strand-specific RNA-seq libraries 7.56
WRN knockout effects upon gene expression in SW48 and OVK18 7.4
ETV7 and interferon response 7.36
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 7.36
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 7.36
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 7.36
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 7.23
FGF2 regulation of gene expression in stable inducible Neurons 7.2
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 7.19
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 7.19
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 7.18
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 7.1
ARID1A and ARID1B loss in HCT116 and TOV21G cells 6.97
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 6.96
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 6.96
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 6.95
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 6.85
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 6.84
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 6.8
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 6.8
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 6.79
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 6.79
RNA-seq in transgenic cells 6.78
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 6.68
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 6.68
RNA expression analysis upon JMJD1C depletion 6.67
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 6.67
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 6.57
CUREfast: Accelerating research with families 6.57
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 6.53
Effect of disulfiram treatment on pediatric high grade glioma 6.46
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 6.33
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 6.3
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 6.28
SRSF2 mutations impair hematopoiesis and alter exon recognition 6.16
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 6.08
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 5.95
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 5.91
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 5.89
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 5.85
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 5.83
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 5.83
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 5.78
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 5.76
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 5.76
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 5.73
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 5.69
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 5.64
Transcriptional responses of melanoma cells to BRAF inhibition 5.58
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 5.53
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 5.52
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 5.28
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 5.21
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 5.15
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 5.15
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 5.15
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 5.14
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 5.09
Knockdown of ADNP in HCT116 colon cancer cells 5.08
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 5.07
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 5.03
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 4.97
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 4.97
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 4.96
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 4.95
SOX11 knockdown in B-ALL cell lines 4.94
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 4.93
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 4.93
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 4.9
CD86 regulates a pro-survival signal in myeloma cells 4.89
iPSC derived motor neuron cultures from C9ORF72 carriers 4.87
Gene expression profile in breast cancer cell lines using RNA sequencing 4.8
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 4.8
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 4.79
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 4.75
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 4.75
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 4.73
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 4.73
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 4.65
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 4.6
Functional Haploid Human Oocytes Generated from Polar Body Genomes 4.52
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 4.52
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 4.4
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 4.39
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 4.38
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 4.38
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 4.38
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 4.38
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 4.38
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 4.36
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 4.34
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 4.31
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 4.31
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 4.3
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 4.24
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 4.22
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 4.21
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 4.21
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 4.2
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 4.19
Gene expression changes after LOC550643 silencing 4.18
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 4.14
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 4.13
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 4.13
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 4.09
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 4.02
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 4.0
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 3.98
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 3.92
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 3.91
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 3.9
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 3.9
A transcriptome-wide divergence in protein translation scales with LIN28B expression 3.9
The Glioma-Infiltrating T Cell Receptor Repertoire 3.89
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 3.89
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 3.88
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 3.86
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 3.84
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 3.83
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 3.81
FBXW7 modulates stress response by post-translational modification of HSF1 3.77
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 3.77
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 3.72
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 3.71
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 3.65
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 3.64
Aneuploidy-induced cellular stresses limit autophagic degradation. 3.62
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 3.61
Tracking distinct RNA populations using efficient and reversible covalent chemistry 3.6
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 3.57
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 3.54
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 3.54
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 3.53
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 3.5
Comparing gene expression in iPSC derived RPE from control and AMD donors 3.43
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 3.42
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 3.41
Transcriptional dependencies in diffuse intrinsic pontine glioma 3.4
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 3.36
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 3.36
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 3.32
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 3.31
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 3.26
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 3.26
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 3.26
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 3.25
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 3.2
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 3.2
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 3.17
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 3.13
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 3.13
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 3.12
Efficient derivation of microglia-like cells from human pluripotent stem cells 3.06
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 3.04
SF3B1 Degron knockdown RNA-seq 3.0
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 2.95
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 2.95
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 2.91
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 2.91
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 2.84
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 2.84
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 2.83
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 2.82
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 2.8
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 2.8
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 2.8
The DNA methylation landscape of human melanoma 2.73
The DNA methylation landscape of human melanoma [RNA-Seq] 2.73
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 2.72
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 2.69
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 2.68
Transcriptome of EBV-infected gastric cancer cell lines 2.66
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 2.64
The effect of insulin on mRNA transcription of human pluripotent stem cells 2.63
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.59
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 2.54
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 2.5
High-throughput sequencing of pluripotent cells 2.44
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 2.42
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 2.37
Trans-differentiation of human adult peripheral blood T cells into neurons 2.34
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 2.34
The cohesin release factor WAPL restricts chromatin loop extension. 2.31
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 2.31
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 2.3
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 2.3
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 2.29
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 2.29
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 2.27
Induction of Cardiomyocyte Proliferation [pz-822_human] 2.18
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 2.18
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 2.18
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 2.17
Human embryonic stem cells in E8 and AKIT culture medium 2.17
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 2.17
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 2.16
Effect of FGF13 depletion on the H460 cell line 2.14
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 2.14
Engineering Patient-Specific Tissue Implants 2.14
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 2.13
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 2.12
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 2.12
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 2.09
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 2.09
The age and genomic integrity of neurons after cortical stroke in humans 2.02
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 2.02
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 2.02
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 1.96
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 1.95
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.93
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 1.92
JAK dependent survival of ALK- ALCL 1.9
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 1.88
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 1.8
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.78
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 1.78
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 1.72
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 1.72
LINE-2 transposable elements are a source of functional human microRNAs and target sites 1.71
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 1.7
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 1.66
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 1.65
Entrectinib Resistance in a Neuroblastoma Xenograft Model 1.59
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 1.54
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 1.54
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 1.53
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 1.5
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 1.5
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 1.49
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 1.47
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.47
Gene expression analysis upon mtDNA depletion [RNA-seq] 1.46
Gene expression analysis upon mtDNA depletion 1.46
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 1.42
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 1.41
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 1.4
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 1.4
A novel target of EZH1/2 for treatment of mantle cell lymphoma 1.38
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 1.35
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 1.35
Transcriptional changes in lymphoma cells induced by LSD1 depletion 1.35
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 1.33
Identification of expressed and conserved human non-coding RNAs 1.32
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.32
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 1.32
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 1.29
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 1.24
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 1.19
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 1.17
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 1.17
Primate-specific gene TMEM14B promotes cortical expansion and folding 1.17
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 1.16
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 1.15
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 1.14
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 1.12
Overexpression and knockdown experiment for circCSNK1G3 1.1
Widespread regulated alternative splicing of single codons accelerates proteome evolution 1.07
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 1.0
Finding missing proteins from epigenetically manipulated human cells 0.99
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 0.96
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 0.95
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 0.93
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 0.88
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 0.85
Gene expression analysis of human hepatocellular cancers 0.84
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 0.82
RNA seq_PDX2_SHP099 0.8
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 0.8
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.75
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.74
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.71
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.71
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 0.71
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.67
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.67
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.64
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 0.61
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 0.6
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 0.59
Effect of ILF3 on translation during homeostasis and the antiviral response 0.57
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 0.56
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.53
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 0.52
Leucegene: AML sequencing (part 6) 0.52
An acquired vulnerability of drug resistant melanoma with therapeutic potential 0.5
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 0.5
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.49
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.48
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 0.4
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 0.39
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 0.37
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.35
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.33
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.33
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 0.32
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.31
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 0.2
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.2
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 0.18
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.17
Hepatic transcriptome of pediatric hepatoblastoma. 0.16
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.13
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.13
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.1
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.1
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.06
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.06
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 0.04
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 0.03
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.03
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 0.02
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation